Medtech

Surgical Robots Market to surpass US$ 16,875.6 Mn by end of 2028, Says Coherent Market Insights

Thursday, October 21, 2021 - 5:30pm

SEATTLE, Oct. 21, 2021 /PRNewswire/ -- Surgical robots are kinds of surgical practices which are carried out using specialized robotic surgical systems.

Key Points: 
  • SEATTLE, Oct. 21, 2021 /PRNewswire/ -- Surgical robots are kinds of surgical practices which are carried out using specialized robotic surgical systems.
  • Growing demand for minimally invasive surgical procedures is a prime factor driving growth of the surgical robots market .
  • Moreover, increasing regulatory approval for the introduction of surgical robots is again anticipated to accelerate growth of the market.
  • A growing number of gynecology surgeries is expected to provide enormous growth opportunities to the market of surgical robots.

Surgical Robots Market to surpass US$ 16,875.6 Mn by end of 2028, Says Coherent Market Insights

Thursday, October 21, 2021 - 5:30pm

SEATTLE, Oct. 21, 2021 /PRNewswire/ -- Surgical robots are kinds of surgical practices which are carried out using specialized robotic surgical systems.

Key Points: 
  • SEATTLE, Oct. 21, 2021 /PRNewswire/ -- Surgical robots are kinds of surgical practices which are carried out using specialized robotic surgical systems.
  • Growing demand for minimally invasive surgical procedures is a prime factor driving growth of the surgical robots market .
  • Moreover, increasing regulatory approval for the introduction of surgical robots is again anticipated to accelerate growth of the market.
  • A growing number of gynecology surgeries is expected to provide enormous growth opportunities to the market of surgical robots.

Life Sciences Operations Outsourcing Is Expected to Grow 9-11% Through 2022 --Everest Group

Thursday, October 21, 2021 - 1:00pm

The rising demand for technological support is one of many trends compelling firms in the life sciences industry to rethink their strategy and operations.

Key Points: 
  • The rising demand for technological support is one of many trends compelling firms in the life sciences industry to rethink their strategy and operations.
  • The rise in spending will be partly utilized to purchase medication and MedTech devices, thereby boosting the life sciences market in the region.
  • Additionally, life sciences firms are increasingly outsourcing their R&D activities in a bid to reduce cost.
  • These trends have generated rapid traction in the life sciences outsourcing market as service providers accelerate their efforts to assist enterprises in augmenting their operations by delivering services and solutions across the life sciences operations value chain.

MedTech Innovator Names Opharmic Technology as 2021 Asia Pacific Final Competition Winner

Thursday, October 21, 2021 - 2:05am

MedTech Innovator , the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, today announced Opharmic Technology as the winner of its 2021 Asia Pacific Accelerator program.

Key Points: 
  • MedTech Innovator , the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, today announced Opharmic Technology as the winner of its 2021 Asia Pacific Accelerator program.
  • The winning company was determined by a live virtual audience vote on Oct. 20th during the MedTech Innovator Asia Pacific 2021 Grand Finals hosted by MedTech Innovator in partnership with APACMed.
  • I am proud to announce Opharmic as this years Asia Pacific MedTech Innovator competition winner for its ultrasonic non-invasive ocular drug delivery device.
  • Congratulations to the winners and finalists of the MedTech Innovator Asia Pacific competition, said Audrey Lok, director of healthcare and biomedical, Enterprise Singapore.

The Engine Releases 2021 Tough Tech Landscape Report Detailing Record Venture Investment in Climate Change, Human Health, and Advanced Systems & Infrastructure Startups

Wednesday, October 20, 2021 - 3:00pm

Theres an urgency to improve human health and agriculture, build resilient systems, enable adaptive infrastructure, and reverse and adapt to climate change.

Key Points: 
  • Theres an urgency to improve human health and agriculture, build resilient systems, enable adaptive infrastructure, and reverse and adapt to climate change.
  • To download the full report and see in-depth data and analyst commentary across the individual Tough Tech sectors, visit the 2021 Tough Tech Landscape .
  • Register here to virtually attend The Engines upcoming 4th Annual Tough Tech Summit October 27 - 28, 2021.
  • The Engine has raised two funds, totaling more than $526 million, and has invested in 37 Tough Tech startups since 2017.

eSight Announces Clinical Research Partnership with Ocular Health Centre’s EyeStart Inc.

Wednesday, October 20, 2021 - 2:00pm

TORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight , today announces a new research and development partnership with the Ocular Health Centre , one of Ontarios top multi-doctor ophthalmology practices, and the cofounders of medical device incubator, EyeStart, Inc.

Key Points: 
  • TORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight , today announces a new research and development partnership with the Ocular Health Centre , one of Ontarios top multi-doctor ophthalmology practices, and the cofounders of medical device incubator, EyeStart, Inc.
  • eSight Chief Technology Officer Charles Lim, Senior Product Manager Khurram Farooq and research scientist Dr. Elena Marenny are leading the project, which will involve a stepwise research study during the developmental process.
  • This collaboration with EyeStart Inc. allows eSight to address patients needs from day one, while creating technology that is developed with physician and industry expert input, said eSight Chief Technology Officer Charles Lim.
  • eSight uses a proprietary combination of hardware and software to enhance vision in its clinically validated head-mounted devices.

FDA SBIR Phase I grant awarded to Triple Ring Technologies

Tuesday, October 19, 2021 - 7:04pm

NEWARK, Calif., Oct. 19, 2021 /PRNewswire/ --Triple Ring Technologies, a co-development firm that helps innovators and entrepreneurs develop breakthrough science-based technologies, is pleased to announce that the company has been awarded an SBIR Phase I grant by the Food and Drug Administration entitled An e-beam sterilization dose map simulation tool.

Key Points: 
  • NEWARK, Calif., Oct. 19, 2021 /PRNewswire/ --Triple Ring Technologies, a co-development firm that helps innovators and entrepreneurs develop breakthrough science-based technologies, is pleased to announce that the company has been awarded an SBIR Phase I grant by the Food and Drug Administration entitled An e-beam sterilization dose map simulation tool.
  • The simulation tool scores the dose distribution on a GPU, as well as implements the physics of radiation sterilization", said Dr. Funk, Sr. Director, Photonics, Imaging & X-Ray at Triple Ring Technologies.
  • Triple Ring Technologies is a co-development company headquartered in Silicon Valley, with offices inBoston,Toronto, andCopenhagen.
  • For more information about Triple Ring Technologies' capabilities, please visit www.tripleringtech.com .

Midwest’s Leading Advanced Manufacturing Event Announces High-Caliber Speaker Lineup

Tuesday, October 19, 2021 - 6:06pm

Advanced Manufacturing Minneapolis , the Midwest's leading end-to-end design and manufacturing event, organized annually by Informa Markets Engineering, today revealed a high-caliber lineup of speakers set to take the stage in-person November 3 and 4, at the Minneapolis Convention Center.

Key Points: 
  • Advanced Manufacturing Minneapolis , the Midwest's leading end-to-end design and manufacturing event, organized annually by Informa Markets Engineering, today revealed a high-caliber lineup of speakers set to take the stage in-person November 3 and 4, at the Minneapolis Convention Center.
  • "This year's education lineup is remarkable, with visionaries from all corners of the medtech and advanced manufacturing fields that play an influential role in progressing the global economy forward sharing their knowledge and returning to face-to-face networking," said Suzanne Deffree, Group Event Director, Informa Markets.
  • These efforts are led by three impactful keynotes crossing medtech and AI, electric vehicles, and innovation in the American Midwest.
  • Minnesota is home to one of the highest per capita of Fortune 500 companies and home to many more key engineering and manufacturing businesses.

FDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso

Tuesday, October 19, 2021 - 5:22pm

The clearance was based on real world safety data collected from over 5,500 patients using the SPRINT PNS System commercially, both on-label and off-label.

Key Points: 
  • The clearance was based on real world safety data collected from over 5,500 patients using the SPRINT PNS System commercially, both on-label and off-label.
  • The expanded indication allows access to the many millions of patients with certain types of head, neck and torso pain.
  • The SPRINT PNS System is not intended to treat pain in the region innervated by the cranial and facial nerves.
  • Our SPRINT PNS System fulfills a critical unmet need for a drug-free, surgery-free option for millions who suffer from chronic pain.

Phillips-Medisize Increases Global Manufacturing Capacity, Capabilities and Collaborations to Drive Drug Delivery, Diagnostic and MedTech Innovations

Tuesday, October 19, 2021 - 1:45pm

Growing Footprint for Local Support, Global Scale

Key Points: 
  • Growing Footprint for Local Support, Global Scale
    To address growing production demands from customers in continental Europe, Phillips-Medisize is building a state-of-the-art medical manufacturing facility in Katowice, Poland.
  • Phillips-Medisize also is expanding production capacity in Suzhou, China to serve both global and regional pharmaceutical and MedTech customers.
  • Once these expansions are complete, Phillips-Medisize will offer nearly three million square feet/280,000 square meters of country- and region-specific manufacturing space and R&D capabilities worldwide.
  • A strong track record of collaboration ensures Phillips-Medisize is at the forefront of the latest advancements in drug delivery, diagnostic and MedTech devices.